Target intelligence / Profile preview

Discs large homolog 1 (DLG1)

Target
DLG1
Molecular classification
Scaffold protein, Membrane-associated guanylate kinase, Other
01

Overview

Discs large homolog 1 (DLG1), also known as synapse-associated protein 97 (SAP97), is a multi-domain scaffolding protein belonging to the membrane-associated guanylate kinase (MAGUK) family. It plays a critical role in establishing and maintaining cell polarity, regulating cell-cell adhesion, and coordinating signal transduction pathways across various tissues. In the nervous system, DLG1 is involved in the trafficking and clustering of ionotropic glutamate receptors (such as AMPA and NMDA receptors) and potassium channels, thereby modulating synaptic plasticity and neuronal excitability.

In epithelial cells, it localizes to adherens junctions and acts as a tumor suppressor by interacting with the adenomatous polyposis coli (APC) protein to negatively regulate cell cycle progression. However, DLG1 can also exhibit oncogenic roles when subverted by viral oncoproteins (such as HPV E6 or Adenovirus E4-ORF1) or when overexpressed in certain malignancies like colorectal cancer, where it promotes cell migration and invasion. Although DLG1 is a highly attractive therapeutic target for cancer, immunological disorders, and neurological diseases, there are currently no approved drugs or clinical-stage small molecules that directly target this protein due to the challenges of targeting intracellular scaffolding proteins.

Other names
Synapse-associated protein 97SAP97Disks large homolog 1hDlg1DLGH1Scribble cell polarity complex component 2Presynaptic protein SAP97
02

Mechanism of action

No approved drugs or clinical-stage small molecules currently target Discs large homolog 1. Experimental strategies focus on disrupting its PDZ domain-mediated protein-protein interactions or modulating its expression using RNA interference or intrabodies.

03

Biological functions

Signal transductionCell cycleCell proliferationImmune responseOther
04

Disease associations

CancerNeurodegenerative diseaseInfectionOther
05

Safety considerations

Congenital hydronephrosisCraniofacial abnormalitiesImpaired renal functionDisruption of epithelial cell polarityAltered synaptic plasticity and cognitive function
06

Biomarkers

DLG1 expression levelDLG1 phosphorylation status

Beyond the preview

Go deeper on Discs large homolog 1 (DLG1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Discs large homolog 1 (DLG1).

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call